A detailed history of Lederer & Associates Investment Counsel transactions in Amgen Inc stock. As of the latest transaction made, Lederer & Associates Investment Counsel holds 6,959 shares of AMGN stock, worth $2.24 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
6,959
Previous 7,053 1.33%
Holding current value
$2.24 Million
Previous $2.2 Million 1.72%
% of portfolio
1.58%
Previous 1.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$309.38 - $337.38 $29,081 - $31,713
-94 Reduced 1.33%
6,959 $2.24 Million
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $91,962 - $111,758
-350 Reduced 4.73%
7,053 $2.2 Million
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $465,413 - $561,813
-1,731 Reduced 18.95%
7,403 $2.11 Million
Q4 2023

Jan 19, 2024

SELL
$255.7 - $288.46 $54,464 - $61,441
-213 Reduced 2.28%
9,134 $2.63 Million
Q3 2023

Oct 23, 2023

SELL
$218.65 - $271.46 $15,961 - $19,816
-73 Reduced 0.77%
9,347 $2.51 Million
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $5,999 - $7,094
-28 Reduced 0.3%
9,420 $2.09 Million
Q1 2023

Apr 17, 2023

SELL
$225.79 - $275.2 $19,869 - $24,217
-88 Reduced 0.92%
9,448 $2.28 Million
Q4 2022

Jan 12, 2023

SELL
$229.03 - $291.01 $76,037 - $96,615
-332 Reduced 3.36%
9,536 $2.51 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $38,382 - $43,288
-171 Reduced 1.7%
9,868 $2.22 Million
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $312,842 - $348,139
-1,356 Reduced 11.9%
10,039 $2.44 Million
Q1 2022

May 24, 2022

SELL
$219.27 - $242.57 $33,329 - $36,870
-152 Reduced 1.32%
11,395 $2.76 Million
Q4 2021

Jan 24, 2022

SELL
$198.88 - $227.6 $26,649 - $30,498
-134 Reduced 1.15%
11,547 $2.6 Million
Q3 2021

Oct 22, 2021

BUY
$212.27 - $248.7 $343,028 - $401,899
1,616 Added 16.06%
11,681 $2.48 Million
Q2 2021

Jul 23, 2021

SELL
$233.58 - $259.14 $50,219 - $55,715
-215 Reduced 2.09%
10,065 $2.45 Million
Q1 2021

Apr 19, 2021

BUY
$221.91 - $258.6 $9,098 - $10,602
41 Added 0.4%
10,280 $2.56 Million
Q4 2020

Jan 25, 2021

SELL
$216.38 - $257.67 $16,012 - $19,067
-74 Reduced 0.72%
10,239 $2.35 Million
Q3 2020

Jan 13, 2021

BUY
$234.65 - $260.95 $10,324 - $11,481
44 Added 0.43%
10,313 $2.62 Million
Q2 2020

Jul 14, 2020

SELL
$197.81 - $242.74 $12,857 - $15,778
-65 Reduced 0.63%
10,269 $2.42 Million
Q1 2020

Apr 20, 2020

BUY
$182.24 - $241.7 $29,705 - $39,397
163 Added 1.6%
10,334 $2.1 Million
Q4 2019

Feb 07, 2020

SELL
$189.21 - $243.2 $486,080 - $624,780
-2,569 Reduced 20.16%
10,171 $2.45 Million
Q3 2019

Oct 07, 2019

SELL
$174.11 - $208.62 $56,585 - $67,801
-325 Reduced 2.49%
12,740 $2.47 Million
Q2 2019

Jul 19, 2019

BUY
$166.7 - $195.41 $66,680 - $78,164
400 Added 3.16%
13,065 $2.41 Million
Q1 2019

Apr 12, 2019

SELL
$180.87 - $203.88 $18,991 - $21,407
-105 Reduced 0.82%
12,665 $2.41 Million
Q4 2018

Jan 25, 2019

SELL
$178.4 - $208.25 $67,792 - $79,135
-380 Reduced 2.89%
12,770 $2.49 Million
Q3 2018

Oct 22, 2018

BUY
$185.29 - $208.89 $57,439 - $64,755
310 Added 2.41%
13,150 $2.73 Million
Q2 2018

Jul 27, 2018

SELL
$166.05 - $186.51 $53,966 - $60,615
-325 Reduced 2.47%
12,840 $2.37 Million
Q1 2018

Apr 09, 2018

SELL
$169.43 - $198.0 $23,889 - $27,918
-141 Reduced 1.06%
13,165 $2.24 Million
Q4 2017

Jan 11, 2018

BUY
$168.79 - $188.59 $46,754 - $52,239
277 Added 2.13%
13,306 $2.31 Million
Q3 2017

Oct 13, 2017

BUY
$167.29 - $191.0 $2.18 Million - $2.49 Million
13,029
13,029 $2.43 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lederer & Associates Investment Counsel Portfolio

Follow Lederer & Associates Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lederer & Associates Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Lederer & Associates Investment Counsel with notifications on news.